AzTrials
AzTrials

Executive DysfunctionNCT06843733

Feasibility Study of Mixed Reality Exergame on Performance and Cortical Outcomes

A study testing Mixed reality exergame and Education in people with Executive Dysfunction and Mild Cognitive Impairment (MCI), run by Mahidol University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The executive dysfunctions are a problem in individuals with MCI which predict conversion to dementia and is positively related to physical activity level. Previous studies found that exercise can prevent executive and physical dysfunctions for people with MCI. Read more about this study

Who is it for?
Ages 60 to 80 yearsHealthy volunteers can take part
What is being tested?
Mixed reality exergame and Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteThailand
Study dates
27 May 2024to 2 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy group: 1) MoCA score > 24; 2) Independent walking without using gait aids; 3) No diagnosis of the dementia by clinician.
  • MCI group: 1) MoCA score between 16 to 24; 2) Independent walking without using gait aids.

Who cannot join

  • Uncontrolled high blood pressure (more than 140/90 mmHg)
  • Hemodialysis
  • Have clinical diagnosis of the disease or symptoms that could influence the performance assessments such as arthritis or severe hand pain which reports by participants and the testing by physiotherapist before testing.
  • History of neurological disorder, such as stroke or other neurodegenerative disorder
  • Taking medicine which affected to functional movement.
  • Unable to follow study protocol.
  • Uncorrected visual or hearing impairment.
  • Positive screening for contraindication of TMS which will be confirmed by TMS screening questionnaire such as uncontrolled seizures.

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Faculty of Physical Therapy, Mahidol University

    Salaya, Changwat Nakhon Pathom, 73170

Other trials in Thailand

About this study

Official title: Feasibility Study of Mixed Reality Exergame on Performance and Cortical Outcomes in Healthy Older Adults and People With Mild Cognitive Impairment

The executive dysfunctions are a problem in individuals with MCI which predict conversion to dementia and is positively related to physical activity level. Previous studies found that exercise can prevent executive and physical dysfunctions for people with MCI. However, the motivation is a critical factor in supporting a sustainable exercise. Exergame is combination of exercise and video game. Enjoyment during playing an exergame can support the exercise motivation. Therefore, we will explore the feasibility of using MR exergame in people with MCI.

Being tested
Mixed reality exergame, Education
Keywords
Feasibility study, Mixed reality, Mild cognitive impairment, Executive Dysfunction
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mixed reality exergameOther

    The participants will play the Balloon Popping game using Hololens2 (Mixed reality glasses) for one hour. The objective of this game will be to pop all the virtual balloons, focusing on training different executive functions such as inhibitory control and cognitive flexibility. When a participant raises a finger in the air, a virtual needle will appear. After that, the participant will move their finger towards a balloon. Successful contact with a balloon will be indicated by the sound of a pop and the visual effect of confetti.

  • EducationOther

    The participants will seat on a chair and watch video clip about MCI and dementia for one hour.

Study groups in NCT06843733
Study groupRoleWhat they receive
Mild cognitive impairmentExperimentalNot described
Receives: Other: Mixed reality exergame; Other: Education
Healthy older adultsOtherNot described
Receives: Other: Mixed reality exergame

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual attention and task switching

    Trail Making Test

    Measured: before and immediately after intervention

  2. Inhibitory control

    Color-Word Stroop Test

    Measured: before and immediately after intervention

  3. Single-task performance

    Box and Block Test

    Measured: before and immediately after intervention

  4. Dual-task performance

    Box and Block with Serial Sevens Test

    Measured: before and immediately after intervention

  5. Cortical outcomes

    Transcranial magnetic stimulation was used for measuring the cortical outcomes, which consist of resting motor threshold, input-output curve of motor evoked potentials recruitment and cortical silent period.

    Measured: before and immediately after intervention

  6. Usability

    System usability scale questionnaire was used for measuring the usability of mixed reality exergame. It consists of 10-item, which are typically rated on a five-point scale. A higher SUS score generally indicates better usability.

    Measured: immediately after Mixed reality exergaming

  7. Motivation

    Intrinsic Motivation Inventory was used for measuring the motivation. It rated on seven-point scale. Higher IMI scores reflect higher levels of motivation.

    Measured: immediately after Mixed reality exergaming

  8. Adverse side effects

    Cybersickness in Virtual Reality Questionnaire was used for assessing cybersickness symptoms, including nausea, vestibular, and oculomotor. The total score is the sum of the three sub-scores. Each question is presented on a 7-item Likert Scale.

    Measured: immediately after Mixed reality exergaming

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2025
  2. Study start27 May 2024
  3. Primary completion2 May 2025
  4. Study completion2 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06843733
Sponsor's protocol ID
MU-CIRB 2024/060.2102
Status last verified
Jun 2026
First submitted
19 Feb 2025
Last updated
22 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: We will share IPD when we receive the consent from participants.

Questions about this trial

What is this clinical trial studying?

A study testing Mixed reality exergame and Education in people with Executive Dysfunction and Mild Cognitive Impairment (MCI), run by Mahidol University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual attention and task switching (time frame: before and immediately after intervention). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in